ForeignExchange Translations Opens Minneapolis Office  
1/12/2011 12:13:52 PM

Newton, MA, January 12, 2010 – Acknowledging the importance of the Twin Cities metropolitan area as a hub for life sciences, ForeignExchange Translations has opened an office in Bloomington, Minnesota, a suburb of Minneapolis. The office will serve as a support hub for the company’s regional clients and be populated by business development, operations and support staff. Having a Twin Cities office and staff enables ForeignExchange to rapidly respond to its clients’ needs and be available for in-person meetings and regional industry events. The Twin Cities area, together with Wisconsin, Iowa, Illinois and the Dakotas represent one of the highest concentrations of medical device companies in the world.

ForeignExchange President, Andres Heuberger, says about the new office, “We have had a long history of working with customers in the Twin Cities and the time is right for us to open an office in the area. We’re excited to become a part of the local life sciences community.”

The office, which opened on January 3rd, is centrally located for quick access to customers, as well as in close proximity to the Minneapolis-St. Paul International Airport. Location and contact information can be found at and below.

ForeignExchange Translations, Inc. 7760 France Avenue South, Suite 1100 Bloomington, MN 55435 +1.952.886.7447 (phone) +1.952.486.8611 (fax)

About ForeignExchange Translations

ForeignExchange Translations, Inc. is redefining the delivery of foreign-language services to the medical device, biotechnology, and pharmaceutical industries. ForeignExchange's solutions are based on its proprietary Multilingual Compliance Process, combining expert linguists, best-of-breed technology, and measurable translation quality in a robust and scalable process that can be deployed in multiple languages simultaneously. ForeignExchange provides Internet globalization, software localization, and technical translation solutions to clients such as Abbott (NYSE:ABT), Pfizer (NYSE:PFE), GlaxoSmithKline

(NYSE:GSK), Baxter (NYSE:BAX), and Medtronic (NYSE:MDT). For more information, please visit